Integrating PARP Inhibitors in mCRPC Therapy: Current Strategies and Emerging Trends

MLA

Thapa B, et al. “Integrating PARP Inhibitors in MCRPC Therapy: Current Strategies and Emerging Trends.” Cancer Management and Research, vol. ume 16, Sept. 2024, pp. 1267–83. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.7099d4bb6250439690b805dadd42278b&authtype=sso&custid=ns315887.

APA

Thapa B, De Sarkar N, Giri S, Sharma K, Kim M, & Kilari D. (2024). Integrating PARP Inhibitors in mCRPC Therapy: Current Strategies and Emerging Trends. Cancer Management and Research, ume 16, 1267–1283.

Chicago

Thapa B, De Sarkar N, Giri S, Sharma K, Kim M, and Kilari D. 2024. “Integrating PARP Inhibitors in MCRPC Therapy: Current Strategies and Emerging Trends.” Cancer Management and Research ume 16 (September): 1267–83. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.7099d4bb6250439690b805dadd42278b&authtype=sso&custid=ns315887.